Search Results - "Lampugnani, Maria G."
-
1
Circulating biomarkers in familial cerebral cavernous malformation
Published in EBioMedicine (01-01-2024)“…Cerebral Cavernous Malformation (CCM) is a rare cerebrovascular disease, characterized by the presence of multiple vascular malformations that may result in…”
Get full text
Journal Article -
2
Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial
Published in Lancet neurology (01-01-2023)“…Observations in people with cerebral cavernous malformations, and in preclinical models of this disorder, suggest that the β-blocker propranolol might reduce…”
Get full text
Journal Article -
3
Circulating biomarkers in familial cerebral cavernous malformationResearch in context
Published in EBioMedicine (01-01-2024)“…Background: Cerebral Cavernous Malformation (CCM) is a rare cerebrovascular disease, characterized by the presence of multiple vascular malformations that may…”
Get full text
Journal Article